Target intelligence / Profile preview

Hemagglutinin protein of Influenza B

Molecular classification
Glycoprotein, Viral surface protein
01

Overview

Hemagglutinin (HA) is the major surface glycoprotein of the influenza B virus. It mediates attachment to host cells and fusion between viral and cellular membranes, enabling viral infectivity. HA is a trimeric protein composed of HA1 and HA2 subunits and is a primary target for neutralizing antibodies, making it crucial for immune recognition and vaccine design. It binds to sialic acid-containing receptors on host cells, initiating endocytosis. Acidic pH in the endosome triggers conformational changes in HA, leading to membrane fusion and release of viral RNA into the cytoplasm. HA is highly variable due to antigenic drift, necessitating frequent updates to influenza vaccines.

02

Mechanism of action

Inhibition of hemagglutinin prevents viral attachment and entry into host cells.

03

Biological functions

Receptor bindingMembrane fusionViral entry
04

Disease associations

Infection
05

Safety considerations

Antigenic drift leading to vaccine escape

Beyond the preview

Go deeper on Hemagglutinin protein of Influenza B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin protein of Influenza B.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call